Novartis data confirm rapid response and high efficacy of Cosentyx in psoriasis patients for first time in China Read more
Pacira to Acquire MyoScience, Adding FDA-approved ioveraº System for Non-opioid Pain Control Read more
AnTolRx Announces Pfizer Exercises Option To License Immune Tolerance Therapy For Potential Treatment Of Type 1 Diabetes Read more
Senior industry experts to discuss recent developments in bacterial immunotherapy at Superbugs & Superdrugs 2019 Read more
Four weeks until SMi’s 11th Annual Adaptive Designs in Clinical Trials Conference in London Read more
Novo Nordisk: Ozempic superior in lowering blood sugar and weight vs placebo, both in combination with SGLT-2 inhibitors Read more